Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves’ disease
- 5 October 2022
- Vol. 173 (1) , 193-200
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Total thyroidectomy vs bilateral subtotal thyroidectomy in patients with Graves’ diseases: a meta‐analysis of randomized clinical trialsClinical Endocrinology, 2013
- Is subtotal thyroidectomy a cost-effective treatment for Graves disease? A cost-effectiveness analysis of the medical and surgical treatment optionsSurgery, 2012
- Treatment Options for Graves Disease: A Cost-Effectiveness AnalysisJournal of the American College of Surgeons, 2009
- Deriving an Algorithm to Convert the Eight Mean SF-36 Dimension Scores into a Mean EQ-5D Preference-Based Score from Published Studies (Where Patient Level Data Are Not Available)Value in Health, 2008
- Radioiodine therapy (RAI) for Graves’ disease (GD) and the effect on ophthalmopathy: a systematic review*Clinical Endocrinology, 2008
- Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysisEuropean Journal of Endocrinology, 2005
- Graves' Disease: A Long-Term Quality-of-Life Follow Up of Patients Randomized to Treatment with Antithyroid Drugs, Radioiodine, or SurgeryThyroid®, 2005
- Long‐term follow‐up study of radioiodine treatment of hyperthyroidismClinical Endocrinology, 2004
- The Efficacy of Thyroidectomy for Graves' Disease: A Meta-analysisJournal of Surgical Research, 2000
- Quality of Life Aspects and Costs in Treatment of Graves' Hyperthyroidism with Antithyroid Drugs, Surgery, or Radioiodine: Results from a Prospective, Randomized StudyThyroid®, 1998